| Response comes in the aftermath of the Dr Bawa-Garba ruling
Related items from OnMedica Bawa-Garba case: was the GMC biased? |
Source: OnMedica
Campaign launched to end ‘pyjama paralysis’ in NHS hospitals
| Initiative aims to get patients dressed to speed up recovery
Related items from OnMedica Third of people sent home too early from psychiatric care |
Source: OnMedica
Study shows huge variation in gluten-free food prescribing
| Variation is not driven by ‘obvious medical factors’
Related items from OnMedica Gluten-free food |
Source: OnMedica
U.S. public may lack understanding of cancer screening
(Reuters Health) – Most people have inaccurate beliefs about what cancer screening tests can do and what they cannot, suggests a recent study from the U.S. National Cancer Institute.
Source: Reuters Medical News
UK pledges cash for Commonwealth education, urges malaria fight
LONDON (Reuters) – British Prime Minister Theresa May will pledge cash to help improve children’s education in the Commonwealth and call for a commitment from fellow leaders to tackle malaria on Tuesday.
Source: Reuters Medical News
Drug suppliers' shares rise as looming Amazon threat appears to ease
(Reuters) – Shares of U.S. drug suppliers rose on Monday after a report that Amazon.com Inc had dropped plans to sell drugs to hospitals, in a boost to a pharmaceutical supply chain rattled by the looming threat of competition from the online retailer.
Source: Reuters Medical News
Coffee industry worried U.S. ruling on cancer warning may widen
MEXICO CITY (Reuters) – The head of the International Coffee Organization criticized a U.S. judge’s decision requiring cancer warnings on coffee sold in California by Starbucks and other retailers, expressing concern that the push for cancer labels may spread.
Source: Reuters Medical News
Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles
LONDON (Reuters) – Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion.
Source: Reuters Medical News
Exclusive: Google unveils vetting process for drug rehab ads
SAN FRANCISCO (Reuters) – Google told Reuters Monday it would resume accepting ads from U.S. addiction treatment centers in July, nearly a year after the Alphabet Inc unit suspended the lucrative category of advertisers for numerous deceptive and misleading ads.
Source: Reuters Medical News
Survival data boosts Merck's Keytruda lead in lung cancer
(Reuters) – Merck & Co’s immunotherapy Keytruda plus chemotherapy significantly improved overall survival in newly-diagnosed patients with advanced non-small cell lung cancer in a closely-watched study, cementing its lead position over Bristol-Myers Squibb Co and others in the most lucrative oncology market.
Source: Reuters Medical News